Pharmaceutical composition for treating asthma
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- 李龙平
- Publication Date
- 2022-08-02
Abstract
Description
technical field
[0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a pharmaceutical composition for treating asthma. Background technique
[0002] Asthma is a common and frequently-occurring respiratory disease, and its incidence is increasing year by year. It is an important disease that affects people's physical and mental health. The risk factors for asthma include host factors (genetic factors) and environmental factors. Genetic factors can be reflected in many patients. For example, in the vast majority of patients’ relatives (blood relationship, nearly three generations), they can be traced back to asthma (repeated cough, wheezing) or other allergic diseases (allergic rhinitis) , atopic dermatitis) history. Most asthma sufferers are allergic and may have allergic rhinitis and / or atopic dermatitis themselves, or are sensitive to common airborne allergens (mites, pollen, pets, molds, etc.), certain foods (nuts, etc.) ,...